Harvard Business Review

MARCH 27, 2018

The velocity in acquiring and exploiting this personal data can help these companies obtain significant market power. He noted his agency’s “particular concerns in digital markets.” Unlike some pharmaceuticals, data-opolies do not charge consumers exorbitant prices. In the U.S., and Europe.

Company 10

Company Advertising Incentives Engineering 10

Harvard Business Review

SEPTEMBER 4, 2015

We’ve found that CEOs of big pharmaceutical companies, for example, are more likely to have a background as company lawyers, salespeople, or finance managers, than one in medicine or pharmaceutical R&D. Pharmaceuticals. The data captured a 20-year period, from 1995 to 2014. Overall, it is a messy picture.

CEO 8

CEO Innovation Pharmaceuticals Merchandising 8

Harvard Business Review

OCTOBER 24, 2014

In addressing the billion-dollar adherence problem, Vitality (since acquired by NANTHEALTH ) considered the interests of the players in the diverse ecosystem, including pharmaceutical companies, retail pharmacies, and health care providers. telemetry, communications and connectivity protocols, electrical hardware engineering).

Productivity 8

Productivity Products Company Engineering 8

Harvard Business Review

MAY 10, 2018

But China also has a huge domestic market for fake goods: many consumers who buy counterfeits do so deliberately, because they want to pay a lower price for goods that look expensive. Do not wait until you actually enter the Chinese market. Invest in anti-counterfeit technology. Fake merchandise accounted for 12.5%

Brand 8

Brand Supply Chain Merchandising Tactics 8

Harvard Business Review

OCTOBER 26, 2017

Today when we talk about business “ clusters ,” we’re usually talking about the technology industry in Silicon Valley, the financial sector in London or New York, or automakers in southern Germany. In the early 1920s, as a result of a growing market for Idrolitina, Gazzoni decided to automate the packaging process. .”

Education 8

Education Pharmaceuticals Innovation Industry 8

Harvard Business Review

JULY 20, 2017

The innovation alone is a herculean task, but imagine being that upstart pioneer trying to develop the technology, while at the same time going up against entrenched, powerful competitors with deep industry knowledge, assets, and channels who’ve been around for a hundred years or more. Sponsored by DXC Technology.

Innovation 12

Innovation Productivity Products Venture Capitalist 12

Harvard Business Review

FEBRUARY 2, 2015

Science and engineering professionals work closely with experienced technicians to produce next-generation batteries, not forged metal. This is the kind of technology—and the type of firm—that will make renewable energy more efficient and more cost-effective. But just as U.S. Applying this standard, we identified 50 U.S.

Industry 8

Industry McKinsey Engineering Innovation 8

Harvard Business Review

JANUARY 5, 2018

The chief marketing officers at consumer products companies, the heads of design at luxury apparel companies, and the heads of logistics at large retailers are cases in point. These are jobs in R&D, technology, and other areas vital to a firm’s strategic direction, product development, and process efficiency.

McKinsey 8

McKinsey Human Resources Reputation Brand 8

Harvard Business Review

NOVEMBER 8, 2017

The health care system in the United States, with its technological prowess and massive infrastructure, often serves as a reference point for rapidly developing economies around the world while they build their own medical systems. Over the same period, pharmaceutical exports have doubled. Insight Center. Transforming Health Care.

Health Care 8

Health Care Tourism Pharmaceuticals Cost 8

Harvard Business Review

NOVEMBER 9, 2011

COOs are relatively common in service industries such as financial services, energy, information technology and telecommunications, but in manufacturing sectors — such as automotive, chemical, and pharmaceutical companies — they are relatively rare.

COO 12

COO Sample Telecommunications Automotive 12

Harvard Business Review

MARCH 28, 2012

The Swiss pharmaceutical giant Roche is nothing if not determined in its quest to acquire Illumina, the San Diego-based leader in genetic-sequencing equipment. This means they're buying drugs that could be similar to others already on or coming soon to the market. billion tender offer directly to shareholders.

Innovation 13

Innovation Company Biotechnology CFO 13

Harvard Business Review

NOVEMBER 12, 2018

With dozens of other genetically engineered therapies moving through clinical trials, the long-promised era of personalized, gene-based medicine seemed to be at hand. ” As this first wave of genetic treatments hits the market, industry leaders face a stark choice. Creating better outcomes at reduced cost. New business models.

Business Model 9

Business Model Insurance Cost Bond 9

Harvard Business Review

JANUARY 31, 2013

First we see major shifts in demand: developing economies such as China and India are morphing from the world's source of low-cost manufacturing capacity to the world's best market opportunities. All over the world, automakers are mastering new drive train technologies. Innovations Are Changing The Way We Design Products.

Globalization 8

Globalization Supply Chain Pharmaceuticals McKinsey 8

Harvard Business Review

OCTOBER 29, 2012

Consider the recent phenomena of shoestring 3D design labs or the biofabrication labs at MIT , which are taking the plunge into synthetic biology with far fewer resources than the genetic engineers at government labs. Some of this may just be the product of the high regulatory costs in pharmaceuticals, but research by Harvard's F.M.

Cost 8

Cost Innovation Wireless Disruptive Innovation 8

Harvard Business Review

OCTOBER 22, 2013

When we surveyed over 300 global executives between 2008 and 2009, one of the primary concerns they expressed was their inability to compete long term without a solid innovation engine that can grow their top line. Three major factors drive convergence: technology, competition, and the customer. Let’s say you’re in the energy sector.

Skills 8

Skills Power Six Sigma Disruptive Innovation 8

Harvard Business Review

NOVEMBER 24, 2015

To make a combination successful, you need to engineer the economies of scale carefully to target the potential source of joint value. Mergers in the beer industry have been driven not by production economies (efficient beer plants are relatively small), but by the benefits of scale in marketing and distribution.

Pharmaceuticals 8

Pharmaceuticals Cost Airlines Productivity 8

Harvard Business Review

JULY 12, 2011

Long term commitment in a world where the technology is advancing almost on a daily basis is difficult to maintain. Boston Scientific a few years back launched a secret project to reverse-engineer the technology of its single-source supplier of coronary stents. Judge McVeigh's punch line applies across a range of industries.

Management 11

Management Airlines How To Pharmaceuticals 11

Harvard Business Review

AUGUST 2, 2011

In reality, each country needs the other to succeed in order to thrive — to finance growth, secure export markets, train talent, transfer technology, and more. For example, pharmaceutical firms license compounds to each other and co-promote products in different markets.

Apparel 15

Apparel Pharmaceuticals Finance Licensing 15

Harvard Business Review

SEPTEMBER 14, 2011

We recently visited the brand-new R&D lab of Dr Reddy's , one of India's leading pharmaceutical firms. Dr Reddy's plan is to leverage Chirotech's scientific capabilities to optimize drug development processes, thus lowering manufacturing costs and speeding time-to-market. Cambridge, U.K. facility in Cambridge Science Park.

Globalization 9

Globalization Innovation Decentralization Chemicals 9

Harvard Business Review

NOVEMBER 20, 2015

He is poised to become the leader in this segment of a multi-billion dollar market. Compliance is crucial for pharmaceutical makers such as Abbott and Amgen – a “ Form 483 ” warning from an FDA inspector can shut down a drug facility in an instant and even land top executives in jail.

Supply Chain 8

Supply Chain Collins Golden Handcuff Pharmaceuticals 8

Harvard Business Review

AUGUST 29, 2011

We discovered some of these pushes and pulls in our research for our upcoming book, Winning the War for Talent in Emerging Markets: Why Women Are the Solution. Women are critical contributors in finance, info-tech, pharmaceutical research, and other industries that are driving the growth of India Inc. We do all of them.".

Stress 14

Stress Human Resources Pharmaceuticals Sharpe 14

Harvard Business Review

FEBRUARY 14, 2014

I’ve been watching the global economy for decades, and it seems to me that growth in the United States is about to speed up, while growth in the emerging markets is slowing down. New technology has turned the U.S., an engine manufacturer, began building an engine for long-haul trucks optimized to run on natural gas.

Chemicals 8

Chemicals Pharmaceuticals Energy Creativity 8

Harvard Business Review

APRIL 15, 2015

million industrial robots are in use or available in various industries including automotive, electronics, rubber and plastics, cosmetics, pharmaceutical, and food and beverage. Their market value is $9.5 Technology' Today, more than 1.3 A more complete history can be found here.).

Definition 8

Definition Ethics Industry Automotive 8

Harvard Business Review

MARCH 16, 2015

Enrique Santacana of ABB North America, a power and automation-technology firm, voiced his concern this way: “An overarching issue was the exposure we had as a company,” Santacana explained, “For example, how information was being used or may be used in a way that was not conducive to good business practices.

CEO 8

CEO Stephenson Pharmaceuticals Globalization 8

Harvard Business Review

OCTOBER 21, 2013

I found myself reflecting on this recently while speaking with two business leaders in one of the world’s great pharmaceutical companies. At Nokia, the senior leadership team was for a long time extraordinarily homogenous (mostly men, mostly from Finland, mostly software engineers, mostly educated in Helsinki). It’s a tough challenge.

Drucker 8

Drucker Diversity Pharmaceuticals Uncertainty 8

Harvard Business Review

OCTOBER 11, 2013

Much as I want to believe that a glaringly good idea will stand on its merits, I have come to realize that just like any product or service, ideas require good marketing if they’re going to reach their intended customers. Capturing the Innovation Mind-Set at Bally Technologies. When You’re Innovating, Think Inside the Box.

Innovation 10

Innovation Christensen Decisionmaking CTO 10

Harvard Business Review

JULY 16, 2013

And 43% cited technology expertise, HR-talent management, international-global expertise, and succession planning as the skills missing most on their boards. pharmaceuticals, biotechnology & life sciences, health care equipment and services); Industrials (e.g., We also looked at results by industry and region.

Telecommunications 8

Telecommunications Biotechnology Health Care Real Estate 8

Harvard Business Review

FEBRUARY 20, 2014

You can read about it in recent issues of The Economist , The New York Times , and in the book The Second Machine Age by Erik Brynjolfsson and Andrew McAfee of the Massachusetts Institute of Technology. True, emerging market countries are getting better at what they do, and even Europe is on the upswing. The arguments are familiar.

Intellectual Capital 8

Intellectual Capital Magazine Pharmaceuticals Creativity 8

Harvard Business Review

NOVEMBER 7, 2012

3M and Google, among others, have given "innovation time off" to their scientists and engineers. Some pharmaceutical scientists will spend an entire career working on drug development without a single one of their products reaching the market. So a more focused approach may be more worthwhile. Tolerance of Failure.

Company 8

Company Stage-Gate Innovation Bureaucracy 8